Center for Substance Abuse Prevention: Notice of Meeting, 11476 [2017-03480]

Download as PDF 11476 Federal Register / Vol. 82, No. 35 / Thursday, February 23, 2017 / Notices Activities, Room # 3G41B, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC9823, Bethesda, MD 20892–9823, (240) 669–5068, zhuqing.li@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: February 17, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–03531 Filed 2–22–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Brian Makela, Chemist, Substance Abuse and Mental Health Services Administration. Substance Abuse and Mental Health Services Administration [FR Doc. 2017–03480 Filed 2–22–17; 8:45 am] rmajette on DSK2TPTVN1PROD with NOTICES Center for Substance Abuse Prevention: Notice of Meeting BILLING CODE 4162–20–P Pursuant to Pub. L. 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB) will meet in person and via web conference on March 20, 2017, from 9:00 a.m. to 5:00 p.m. EDT and March 21, 2017 from 9:00 a.m. to 2:00 p.m. EDT. The Board will meet in open session on March 20, 2017, from 9:00 a.m. to 2:00 p.m. , to provide updates on the Mandatory Guidelines for Federal Workplace Drug Testing Programs, provide data on hair testing programs currently in use in the private sector, research data on marijuana edibles, and the most current data from Quest Diagnostics Drug Testing Index. The board will meet in closed session on March 20, 2017, from 2:00 p.m. to 5:00 p.m. EDT and on March 21, 2017, from 9:00 a.m. to 2:00 p.m. EDT to hear about current confidential practices in the hair testing industry, and to discuss proposals for the Oral Fluid Mandatory Guidelines for Federal Workplace Drug Testing Programs. Therefore, these portions of the meeting are closed to the public as determined by the Administrator, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, Section 10(d). Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees Web site, http:// www.samhsa.gov/about-us/advisorycouncils/drug-testing-advisory-boarddtab, or by contacting Brian Makela. Committee Name: Substance Abuse and Mental Health Services VerDate Sep<11>2014 14:10 Feb 22, 2017 Jkt 241001 Administration’s Center for Substance Abuse Prevention Drug Testing Advisory Board. Dates/Time/Type: March 20, 2016, from 9:00 a.m. to 2:00 p.m., EDT: OPEN. March 20, 2016, from 2:00 p.m. to 5:00 p.m., EDT: CLOSED. March 21, 2016, from 9:00 a.m. to 2:00 p.m., EDT: CLOSED. Place: Parklawn Building, Room 5W07, 5600 Fishers Lane, Rockville, Maryland 20857. Contact: Brian Makela, Division of Workplace Programs, 5600 Fishers Lane, Room 16N02B, Rockville, Maryland 20857, Telephone: 240–276–2600, Fax: 240–276–2610, Email: brian.makela@ samhsa.hhs.gov. DEPARTMENT OF HOMELAND SECURITY U.S. Citizenship and Immigration Services [OMB Control Number 1615—NEW Agency Information Collection Activities: Independent Evaluation of the Systematic Alien Verification for Entitlements (SAVE) Program, Form G–1503; New Collection U.S. Citizenship and Immigration Services, Department of Homeland Security. ACTION: 60-Day Notice. AGENCY: The Department of Homeland Security (DHS), U.S. Citizenship and Immigration (USCIS) invites the general public and other Federal agencies to comment upon this proposed new collection of information. In accordance with the Paperwork Reduction Act (PRA) of 1995, the information collection notice is published in the Federal Register to obtain comments regarding the nature of the information collection, the categories of respondents, the estimated burden (i.e. the time, effort, and resources used by the respondents to respond), the estimated cost to the respondent, and the actual information collection instruments. SUMMARY: Comments are encouraged and will be accepted for 60 days until April 24, 2017. ADDRESSES: All submissions received must include the OMB Control Number 1615–NEW in the body of the letter, the DATES: PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 agency name and Docket ID USCIS– 2016–0007. To avoid duplicate submissions, please use only one of the following methods to submit comments: (1) Online. Submit comments via the Federal eRulemaking Portal Web site at http://www.regulations.gov under eDocket ID number USCIS–2016–0007; (2) Mail. Submit written comments to DHS, USCIS, Office of Policy and Strategy, Chief, Regulatory Coordination Division, 20 Massachusetts Avenue NW., Washington, DC 20529–2140. FOR FURTHER INFORMATION CONTACT: USCIS, Office of Policy and Strategy, Regulatory Coordination Division, Samantha Deshommes, Chief, 20 Massachusetts Avenue NW., Washington, DC 20529–2140, telephone number 202–272–8377 (This is not a toll-free number. Comments are not accepted via telephone message). Please note contact information provided here is solely for questions regarding this notice. It is not for individual case status inquiries. Applicants seeking information about the status of their individual cases can check Case Status Online, available at the USCIS Web site at http://www.uscis.gov, or call the USCIS National Customer Service Center at 800–375–5283 (TTY 800–767– 1833). SUPPLEMENTARY INFORMATION: Comments You may access the information collection instrument with instructions, or additional information by visiting the Federal eRulemaking Portal site at: http://www.regulations.gov and enter USCIS–2016–0007 in the search box. Regardless of the method used for submitting comments or material, all submissions will be posted, without change, to the Federal eRulemaking Portal at http://www.regulations.gov, and will include any personal information you provide. Therefore, submitting this information makes it public. You may wish to consider limiting the amount of personal information that you provide in any voluntary submission you make to DHS. DHS may withhold information provided in comments from public viewing that it determines may impact the privacy of an individual or is offensive. For additional information, please read the Privacy Act notice that is available via the link in the footer of http://www.regulations.gov. Written comments and suggestions from the public and affected agencies should address one or more of the following four points: (1) Evaluate whether the proposed collection of information is necessary E:\FR\FM\23FEN1.SGM 23FEN1

Agencies

[Federal Register Volume 82, Number 35 (Thursday, February 23, 2017)]
[Notices]
[Page 11476]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03480]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention: Notice of Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory 
Board (DTAB) will meet in person and via web conference on March 20, 
2017, from 9:00 a.m. to 5:00 p.m. EDT and March 21, 2017 from 9:00 a.m. 
to 2:00 p.m. EDT.
    The Board will meet in open session on March 20, 2017, from 9:00 
a.m. to 2:00 p.m. , to provide updates on the Mandatory Guidelines for 
Federal Workplace Drug Testing Programs, provide data on hair testing 
programs currently in use in the private sector, research data on 
marijuana edibles, and the most current data from Quest Diagnostics 
Drug Testing Index.
    The board will meet in closed session on March 20, 2017, from 2:00 
p.m. to 5:00 p.m. EDT and on March 21, 2017, from 9:00 a.m. to 2:00 
p.m. EDT to hear about current confidential practices in the hair 
testing industry, and to discuss proposals for the Oral Fluid Mandatory 
Guidelines for Federal Workplace Drug Testing Programs. Therefore, 
these portions of the meeting are closed to the public as determined by 
the Administrator, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and 
(9)(B), and 5 U.S.C. App. 2, Section 10(d).
    Meeting information and a roster of DTAB members may be obtained by 
accessing the SAMHSA Advisory Committees Web site, http://www.samhsa.gov/about-us/advisory-councils/drug-testing-advisory-board-dtab, or by contacting Brian Makela.
    Committee Name: Substance Abuse and Mental Health Services 
Administration's Center for Substance Abuse Prevention Drug Testing 
Advisory Board.
    Dates/Time/Type: March 20, 2016, from 9:00 a.m. to 2:00 p.m., EDT: 
OPEN. March 20, 2016, from 2:00 p.m. to 5:00 p.m., EDT: CLOSED. March 
21, 2016, from 9:00 a.m. to 2:00 p.m., EDT: CLOSED.
    Place: Parklawn Building, Room 5W07, 5600 Fishers Lane, Rockville, 
Maryland 20857.
    Contact: Brian Makela, Division of Workplace Programs, 5600 Fishers 
Lane, Room 16N02B, Rockville, Maryland 20857, Telephone: 240-276-2600, 
Fax: 240-276-2610, Email: brian.makela@samhsa.hhs.gov.

Brian Makela,
Chemist, Substance Abuse and Mental Health Services Administration.
[FR Doc. 2017-03480 Filed 2-22-17; 8:45 am]
BILLING CODE 4162-20-P